Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
ReShape Lifesciences Inc. (RSLS)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Medical Devices
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
4 Aug 2023
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
22,949
-1%
435
$0.89
$386.48
BUY
31 Mar 2023
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
23,490
+285%
17,399
$1.54
$26,160.90
SELL
17 Nov 2022
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
327,617
-53%
372,113
$0.17
$62,938.37
SELL
4 Nov 2022
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
335,271
-2%
8,393
$0.27
$2,286.84
SELL
4 Oct 2022
STANKOVICH THOMAS
CFO, Officer
ReShape Lifesciences Inc.
(RSLS)
341,154
-2%
8,293
$0.28
$2,329.09
SELL
6 Sep 2022
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
346,963
-1%
4,828
$0.39
$1,882.92
SELL
5 Aug 2022
Bandy Barton P.
President and CEO, Director, Officer
ReShape Lifesciences Inc.
(RSLS)
773,098
-1%
11,674
$0.47
$5,486.78
SELL
5 Aug 2022
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
351,791
-1%
4,728
$0.47
$2,222.16
SELL
1 Jul 2022
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
356,519
-1%
4,630
$0.55
$2,546.50
SELL
1 Jul 2022
Bandy Barton P.
President and CEO, Director, Officer
ReShape Lifesciences Inc.
(RSLS)
784,772
-1%
11,442
$0.55
$6,293.10
SELL
1 Jun 2022
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
361,149
-1%
4,478
$0.96
$4,298.88
SELL
1 Jun 2022
Bandy Barton P.
President and CEO, Director, Officer
ReShape Lifesciences Inc.
(RSLS)
798,913
-1%
11,309
$0.95
$10,770.54
BUY
31 May 2022
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
345,705
+6%
20,000
$0.92
$18,422.32
SELL
5 May 2022
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
345,627
-1%
4,529
$0.77
$3,487.33
SELL
5 May 2022
Bandy Barton P.
President and CEO, Director, Officer
ReShape Lifesciences Inc.
(RSLS)
807,523
-1%
11,417
$0.77
$8,791.09
SELL
1 Apr 2022
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
350,156
-1%
5,038
$1.13
$5,692.94
SELL
1 Apr 2022
Bandy Barton P.
President and CEO, Director, Officer
ReShape Lifesciences Inc.
(RSLS)
818,940
-1%
11,063
$1.13
$12,501.19
SELL
28 Feb 2022
STANKOVICH THOMAS
CFO, Officer
ReShape Lifesciences Inc.
(RSLS)
355,194
-1%
3,658
$1.06
$3,877.48
SELL
28 Feb 2022
Bandy Barton P.
President and CEO, Director, Officer
ReShape Lifesciences Inc.
(RSLS)
830,003
-0%
6,538
$1.06
$6,930.28
SELL
31 Jan 2022
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
358,852
-1%
3,684
$1.22
$4,494.48
SELL
31 Jan 2022
Bandy Barton P.
President and CEO, Director, Officer
ReShape Lifesciences Inc.
(RSLS)
836,541
-0%
8,324
$1.22
$10,155.28
SELL
4 Jan 2022
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
362,536
-0%
3,171
$1.78
$5,644.38
SELL
4 Jan 2022
Bandy Barton P.
President and CEO, Director, Officer
ReShape Lifesciences Inc.
(RSLS)
844,865
-0%
7,150
$1.79
$12,798.50
SELL
2 Dec 2021
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
365,707
-1%
4,304
$1.83
$7,863.41
SELL
2 Dec 2021
Bandy Barton P.
President and CEO, Director, Officer
ReShape Lifesciences Inc.
(RSLS)
852,015
-1%
13,427
$1.83
$24,571.41
BUY
18 Nov 2021
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
370,011
+5%
20,000
$2.02
$40,400.00
SELL
2 Nov 2021
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
350,011
-1%
4,320
$2.69
$11,620.80
SELL
2 Nov 2021
Bandy Barton P.
President and CEO, Director, Officer
ReShape Lifesciences Inc.
(RSLS)
865,442
-1%
13,505
$2.69
$36,328.45
SELL
1 Oct 2021
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
354,331
-1%
3,660
$2.76
$10,101.60
SELL
1 Oct 2021
Bandy Barton P.
President and CEO, Director, Officer
ReShape Lifesciences Inc.
(RSLS)
878,947
-1%
12,565
$2.77
$34,805.05
BUY
30 Aug 2021
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
32,613
+85%
15,000
$3.43
$51,435.00
BUY
20 Aug 2021
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
17,613
+574%
15,000
$3.22
$48,285.00
SELL
22 Jul 2021
STANKOVICH THOMAS
Chief Financial Officer, Officer
ReShape Lifesciences Inc.
(RSLS)
357,991
-11%
48,366
$2.89
$139,777.75
SELL
22 Jul 2021
Bandy Barton P.
President and CEO, Director, Officer
ReShape Lifesciences Inc.
(RSLS)
891,512
-24%
294,494
$2.89
$851,087.70
SELL
22 Jul 2021
GLADNEY DAN W
Director
ReShape Lifesciences Inc.
(RSLS)
283,922
-41%
200,000
$2.99
$598,000.00
SELL
16 Jun 2021
ARMISTICE CAPITAL, LLC
10% Owner
ReShape Lifesciences Inc.
(RSLS)
105,873
-87%
767,823
$18.53
$14,230,403.00
BUY
12 Nov 2019
Plovanic William J.
President & CEO, Director, Officer
OBALON THERAPEUTICS INC
(OBLN)
106,806
+25%
21,666.668
$4.98
$107,822.00
BUY
6 Aug 2019
INTERWEST PARTNERS X LP
10% Owner
OBALON THERAPEUTICS INC
(OBLN)
380,224
+2%
8,333.334
$12.00
$100,000.00
BUY
6 Aug 2019
HOWE LESLEY H
Director
OBALON THERAPEUTICS INC
(OBLN)
19,397
+12%
2,083.334
$12.00
$25,000.00
BUY
6 Aug 2019
Plovanic William J.
President & CFO, Director, Officer
OBALON THERAPEUTICS INC
(OBLN)
41,806
+11%
4,166.667
$12.00
$50,000.00
BUY
6 Aug 2019
Kamdar Kim P.
Director
OBALON THERAPEUTICS INC
(OBLN)
27,148
+18%
4,166.667
$12.00
$50,000.00
BUY
6 Aug 2019
Brister Mark
Chief Technology Officer, Officer
OBALON THERAPEUTICS INC
(OBLN)
38,865
+4%
1,666.667
$12.00
$20,000.00
BUY
6 Aug 2019
DOMAIN PARTERS VII L P
10% Owner
OBALON THERAPEUTICS INC
(OBLN)
813,433
+11%
83,333.336
$12.00
$1,000,000.00
BUY
6 Aug 2019
MacDonald Robert J
Chief Retail Officer, Officer
OBALON THERAPEUTICS INC
(OBLN)
5,245
+46%
1,666.667
$12.00
$20,000.00
BUY
6 Aug 2019
Hussainy Nooshin
VP of Finance, Officer
OBALON THERAPEUTICS INC
(OBLN)
16,340
+11%
1,666.667
$12.00
$20,000.00
BUY
6 Aug 2019
Rasdal Andrew P
Exec Chairman of the Board, Director, Officer
OBALON THERAPEUTICS INC
(OBLN)
77,892
+5%
4,166.667
$12.00
$50,000.00
BUY
6 Aug 2019
VandenBerg Amy
Chief Clinical & Reg Officer, Officer
OBALON THERAPEUTICS INC
(OBLN)
11,764
+7%
833.333
$12.00
$10,000.00
BUY
6 Aug 2019
Stevenson Sharon
Director
OBALON THERAPEUTICS INC
(OBLN)
18,061
+16%
2,500
$12.00
$30,000.00
BUY
23 Aug 2018
INTERWEST PARTNERS X LP
10% Owner
OBALON THERAPEUTICS INC
(OBLN)
3,552,239
+1%
36,630.035
$54.60
$1,999,999.90
BUY
23 Aug 2018
Kamdar Kim P.
Director
OBALON THERAPEUTICS INC
(OBLN)
68,345
+2%
1,831.5
$54.60
$99,999.91
BUY
23 Aug 2018
DOMAIN PARTERS VII L P
10% Owner
OBALON THERAPEUTICS INC
(OBLN)
5,634,329
+0%
54,945.305
$54.60
$3,000,013.50
BUY
15 Mar 2018
Drake Neil
VP Research and Development, Officer
OBALON THERAPEUTICS INC
(OBLN)
26,850
+0%
166.667
$118.66
$19,777.50
BUY
13 Mar 2018
Plovanic William J.
Chief Financial Officer, Officer
OBALON THERAPEUTICS INC
(OBLN)
15,000
+7%
1,000
$121.33
$121,330.34
BUY
12 Oct 2016
Kamdar Kim P.
Director
OBALON THERAPEUTICS INC
(OBLN)
13,400
+3%
446.667
$450.00
$201,000.00
BUY
12 Oct 2016
Norwood Matthew
VP of Sales, Officer
OBALON THERAPEUTICS INC
(OBLN)
1,000
+3%
33.333
$450.00
$15,000.00
Home